MariJ Pharmaceuticals, Inc.

The Company is comprised of a diversified portfolio of medical marijuana products, services, technology, and businesses solely focused on the medical marijuana cannabis and hemp industries.

Customers Support

Have any question? Something is not clear? We reply to all questions within

MariJ Gallery

Contact Info

We say what we do, we do what we say, and we're looking forward to prove it to you.

  • 13575 58th Street, Suite# 138, Clearwater, FL 33607
  • (727) 678- 4420
  • (727) 678- 4420
  • info@marijagricultural.com
English French Spanish
Log in

Register


Our MariJ Pharmaceuticals, Inc. Board understands and acts on the fundamental principle that good corporate governance is critical to organizational success and the protection of shareholder value.  As one of our first acts of the Committee, we issued a new set of principles to govern the operation of the Board and the Board Committees, both present and future.

In keeping with the Board's forward thinking and accountability to shareholders, we have created “The Principles” for our members to uphold as stated in the MariJ Pharmaceuticals, Inc. Corporate documents. This living document, reviewed at least annually and updated periodically in response to changing regulatory requirements, will evolve best practices and concerns of our shareholder and all stakeholders.

Board of Directors Information 2014/2015
Size of Board 7 Members
Average Age of Directors 44 Yrs
Diverse Board Yes
Annual Election of All Directors 2015
Director Tenure - Average Years 8 Yrs
Majority Voting for Directors 51%
Separate Chairman & CEO Yes
Lead Independent Director David Hill
Independent Directors Meet Without Management Present 12
Annual Board and Committee Self-Evaluations 4
Board Orientation/Education Program 2 Weeks
Number of Board Meetings Held or Scheduled 12
Code of Business Conduct and Ethics for Directors Doc 4.28B
Corporate Compliance Program Doc 7.28B
Rigorous Process and Expanded Disclosure Related to Corporate Political Expenditures 55
Company Annual Revenue Website
Microsoft Corp. 77.65B microsoft.com
Apple Inc. 170.87B apple.com
Google Inc. Cl A 49.96B google.com
Intel Corp. 53.34B intel.com
Advanced Micro Devices Inc. 5.42B amd.com
NVIDIA Corp. 4.28B nvidia.com
Company Annual Revenue Website
Microsoft Corp. 77.65B microsoft.com
Apple Inc. 170.87B apple.com
Google Inc. Cl A 49.96B google.com
Intel Corp. 53.34B intel.com
Advanced Micro Devices Inc. 5.42B amd.com
NVIDIA Corp. 4.28B nvidia.com
The Board of Directors (the "Board") of MariJ Pharmaceuticals, Inc.. (the "Company") has adopted the following Code of Business Conduct and Ethics (the "Code ") for directors of the Company. This Code is intended to focus the Board and each director on areas of ethical risk; provide guidance to directors to help them recognize and deal with ethical issues; provide mechanisms to report unethical conduct; and help foster a culture of honesty and accountability.

Each director must comply with the letter and spirit of this Code.

No code or policy can anticipate every situation that may arise, or replace the thoughtful behavior of an ethical director. Directors are encouraged to bring questions about particular circumstances that may implicate one or more of the provisions of this Code to the attention of the Chairman of the Corporate Governance Committee.

1. CONFLICT OF INTEREST
Directors must avoid any conflicts of interest between the director and the Company. Any situation that involves, or may reasonably be expected to involve, a conflict of interest with the Company, should be disclosed promptly to the Chairman of the Corporate Governance Committee. A "conflict of interest" can occur when:

o A director's personal interest is adverse to – or may appear to be adverse to – the interests of the Company as a whole.
o A director, or a member of his or her immediate family as defined by the New York Stock Exchange1 receives improper personal benefits as a result of his or her position as a director of the Company.
Some of the more common conflicts which directors should avoid are listed below:
c. Relationship of Company with third-parties. Directors may not receive a personal benefit from a person or firm that is seeking to do business or to retain business with the Company. A director shall recues him or herself from any Company Board decision involving another firm or company with which the director is affiliated.
d. Compensation from non-Company sources. Directors may not accept compensation (in any form) for services performed for the Company from any source other than the Company.
e. Gifts. Directors may not offer, give or receive gifts or other items of value from persons or entities who deal or seek to deal with the Company in those cases where any such gift has the purpose or effect of influencing (or could be perceived as influencing) the directors’ actions as members of the Board, or where acceptance of the gifts could create the appearance of a conflict of interest.
f. Personal use of Company assets. Directors may not use Company assets, labor or information for personal use unless approved by the Chairman of the Corporate Governance Committee or as part of a compensation or expense reimbursement program available to all directors.

2. CORPORATE OPPORTUNITIES
Directors are prohibited from:
. Taking for themselves or companies with which they are affiliated opportunities that are discovered through the use of Company property, Company information or position as a director;
a. Using the Company's property or information for personal gain; or
b. Competing with the Company for business opportunities. However, if the Company's disinterested directors determine that the Company will not pursue an opportunity that relates to the Company's business, a director may then do so.

3. CONFIDENTIALITY
Directors must maintain the confidentiality of information entrusted to them by the Company and any other confidential information about the Company that comes to them, from whatever source, in their capacity as a director, except when disclosure is authorized or legally mandated. For purposes of this Code, "confidential information" includes all non-public information relating to the Company.

4. ENCOURAGING THE REPORTING OF ANY ILLEGAL OR UNETHICAL BEHAVIOR
Directors should promote ethical behavior and take steps to ensure the Company:
. Encourages employees to talk to supervisors, managers and other appropriate personnel when in doubt about the best course of action in a particular situation.
a. Encourages employees to report violations of laws, rules, regulations or the Company's Code of Conduct to appropriate personnel; and
b. Informs employees that the Company will not allow retaliation for reports made in good faith.

5. COMPLIANCE STANDARDS
Directors should communicate any suspected violations of this Code promptly to the Chairman of the Audit Committee. Violations will be investigated by the Board of Directors or by persons designated by the Board, and appropriate action will be taken in the event of any violations of the Code.

6. WAIVER OF CODE OF BUSINESS CONDUCT AND ETHICS
Any waiver of this Code may be made only by the Board of Directors or a Committee of the Board and must be promptly disclosed to the Company’s shareholders.